Lung Cancer | ScienceGate

Short communication: The activity of brigatinib in patients with disease progression after next generation anaplastic lymphoma tyrosine kinase inhibitors and an exploratory analysis of circulating tumor DNA

Lung Cancer ◽

10.1016/j.lungcan.2021.12.019 ◽

2022 ◽

Author(s):

Thomas E. Stinchcombe ◽

Xiaofei Wang ◽

Robert C. Doebele ◽

Leylah M. Drusbosky ◽

David E. Gerber ◽

...

Keyword(s):

Tyrosine Kinase ◽

Disease Progression ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Short Communication ◽

Circulating Tumor Dna ◽

Exploratory Analysis ◽

Next Generation ◽

Anaplastic Lymphoma ◽

Tumor Dna

Download Full-text

The genomic mutational landscape and its correlation with TMB, PD-L1 expression and CD8+ T cell infiltration in Chinese Lung Large Cell Neuroendocrine Carcinoma

Lung Cancer ◽

10.1016/j.lungcan.2022.01.007 ◽

2022 ◽

Author(s):

Ye Li ◽

Xinying Shi ◽

Beibei Mao ◽

Lingxiong Wang ◽

Lijia Wu ◽

...

Keyword(s):

T Cell ◽

Neuroendocrine Carcinoma ◽

Large Cell ◽

Cd8 T Cell ◽

Large Cell Neuroendocrine Carcinoma ◽

Cell Infiltration ◽

Mutational Landscape ◽

T Cell Infiltration

Download Full-text

Survival after surgery for clinical stage I non-small-cell lung cancer with interstitial pneumonia

Lung Cancer ◽

10.1016/j.lungcan.2021.12.018 ◽

2022 ◽

Author(s):

Mariko Fukui ◽

Kazuhiro Suzuki ◽

Katsutoshi Ando ◽

Takeshi Matsunaga ◽

Aritoshi Hattori ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Interstitial Pneumonia ◽

Cell Lung Cancer ◽

Clinical Stage ◽

Small Cell ◽

Stage I ◽

Small Cell Lung

Download Full-text

Editorial Board

Lung Cancer ◽

10.1016/s0169-5002(21)00650-4 ◽

2022 ◽

Vol 163 ◽

pp. iii

Download Full-text

Surgical Approach Does Not Influence Changes in Circulating Immune Cell Populations Following Lung Cancer Resection

Lung Cancer ◽

10.1016/j.lungcan.2022.01.001 ◽

2022 ◽

Author(s):

Nathaniel Deboever ◽

Daniel J. McGrail ◽

Younghee Lee ◽

Hai T. Tran ◽

Kyle G. Mitchell ◽

...

Keyword(s):

Lung Cancer ◽

Surgical Approach ◽

Immune Cell ◽

Cell Populations ◽

Cancer Resection

Download Full-text

ALK fusion variant 3a/b, concomitant mutations, and high PD-L1 expression were associated with unfavorable clinical response to second-generation ALK TKIs in patients with advanced ALK-rearranged non-small cell lung cancer (GASTO 1061)

Lung Cancer ◽

10.1016/j.lungcan.2022.01.006 ◽

2022 ◽

Author(s):

Meichen Li ◽

Xue Hou ◽

Jing Chen ◽

Baishen Zhang ◽

Na Wang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Clinical Response ◽

Cell Lung Cancer ◽

Second Generation ◽

Small Cell ◽

Small Cell Lung

Download Full-text

Acknowledgement to reviewers

Lung Cancer ◽

10.1016/j.lungcan.2021.12.017 ◽

2022 ◽

Download Full-text

Radicality of lymphadenectomy in lung cancer resections by thoracotomy and video-assisted thoracoscopic approach: a prospective, multicentre and propensity-score adjusted study

Lung Cancer ◽

10.1016/j.lungcan.2022.01.004 ◽

2022 ◽

Author(s):

Carme Obiols ◽

Sergi Call ◽

Ramón Rami-Porta ◽

Ángeles Jaén ◽

David Gómez de Antonio ◽

...

Keyword(s):

Lung Cancer ◽

Propensity Score ◽

Thoracoscopic Approach ◽

Video Assisted

Download Full-text

Image-Guided Interventional Radiological Delivery of Chimeric Antigen Receptor (CAR) T Cells for Pleural Malignancies in a Phase I/II Clinical Trial

Lung Cancer ◽

10.1016/j.lungcan.2022.01.003 ◽

2022 ◽

Author(s):

Mario Ghosn ◽

Waseem Cheema ◽

Amy Zhu ◽

Jennifer Livschitz ◽

Majid Maybody ◽

...

Keyword(s):

Clinical Trial ◽

T Cells ◽

Phase I ◽

Chimeric Antigen Receptor ◽

Antigen Receptor ◽

Image Guided ◽

Car T Cells ◽

Car T

Download Full-text

Lung Cancer
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Short communication: The activity of brigatinib in patients with disease progression after next generation anaplastic lymphoma tyrosine kinase inhibitors and an exploratory analysis of circulating tumor DNA

The genomic mutational landscape and its correlation with TMB, PD-L1 expression and CD8+ T cell infiltration in Chinese Lung Large Cell Neuroendocrine Carcinoma

Survival after surgery for clinical stage I non-small-cell lung cancer with interstitial pneumonia

Editorial Board

Surgical Approach Does Not Influence Changes in Circulating Immune Cell Populations Following Lung Cancer Resection

ALK fusion variant 3a/b, concomitant mutations, and high PD-L1 expression were associated with unfavorable clinical response to second-generation ALK TKIs in patients with advanced ALK-rearranged non-small cell lung cancer (GASTO 1061)

Acknowledgement to reviewers

Radicality of lymphadenectomy in lung cancer resections by thoracotomy and video-assisted thoracoscopic approach: a prospective, multicentre and propensity-score adjusted study

Image-Guided Interventional Radiological Delivery of Chimeric Antigen Receptor (CAR) T Cells for Pleural Malignancies in a Phase I/II Clinical Trial

Contents

Export Citation Format

Lung CancerLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Short communication: The activity of brigatinib in patients with disease progression after next generation anaplastic lymphoma tyrosine kinase inhibitors and an exploratory analysis of circulating tumor DNA

The genomic mutational landscape and its correlation with TMB, PD-L1 expression and CD8+ T cell infiltration in Chinese Lung Large Cell Neuroendocrine Carcinoma

Survival after surgery for clinical stage I non-small-cell lung cancer with interstitial pneumonia

Editorial Board

Surgical Approach Does Not Influence Changes in Circulating Immune Cell Populations Following Lung Cancer Resection

ALK fusion variant 3a/b, concomitant mutations, and high PD-L1 expression were associated with unfavorable clinical response to second-generation ALK TKIs in patients with advanced ALK-rearranged non-small cell lung cancer (GASTO 1061)

Acknowledgement to reviewers

Radicality of lymphadenectomy in lung cancer resections by thoracotomy and video-assisted thoracoscopic approach: a prospective, multicentre and propensity-score adjusted study

Image-Guided Interventional Radiological Delivery of Chimeric Antigen Receptor (CAR) T Cells for Pleural Malignancies in a Phase I/II Clinical Trial

Contents

Lung Cancer
Latest Publications